Publication | Open Access
The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma
58
Citations
33
References
2019
Year
In EBV<sup>-pos</sup> DLBCL, the TME is immuno-tolerogenic and may explain the poor outcomes seen in this subtype of DLBCL.
| Year | Citations | |
|---|---|---|
Page 1
Page 1